{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:46:01Z","timestamp":1761630361939},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,11,23]],"date-time":"2004-11-23T00:00:00Z","timestamp":1101168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s10067-004-1027-z","type":"journal-article","created":{"date-parts":[[2004,11,22]],"date-time":"2004-11-22T10:31:28Z","timestamp":1101119488000},"page":"352-357","source":"Crossref","is-referenced-by-count":13,"title":["Clinical significance of von Willebrand factor in patients with adult dermatomyositis"],"prefix":"10.1007","volume":"24","author":[{"given":"Toshiyuki","family":"Komiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Negoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,11,23]]},"reference":[{"key":"1027_CR1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(99)05157-0","volume":"355","author":"JP Callen","year":"2000","unstructured":"Callen JP (2000) Dermatomyositis. Lancet 355:53\u201357","journal-title":"Lancet"},{"key":"1027_CR2","first-page":"1527","volume":"26","author":"Y Nawata","year":"1999","unstructured":"Nawata Y, Kurasawa K, Takabayashi K et al (1999) Corticosteroid resistant interstitial pneumonitis in dermatomyositis\/polymyositis: prediction and treatment with cyclosporine. J Rheumatol 26:1527\u20131533","journal-title":"J Rheumatol"},{"key":"1027_CR3","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","volume":"164","author":"WW Douglas","year":"2001","unstructured":"Douglas WW, Tazelaar HD, Hartman TE et al (2001) Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164:1182\u20131185","journal-title":"Am J Respir Crit Care Med"},{"key":"1027_CR4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B et al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96\u2013100","journal-title":"Lancet"},{"key":"1027_CR5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"1027_CR6","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1002\/ana.410370709","volume":"37","author":"MC Dalakas","year":"1995","unstructured":"Dalakas MC (1995) Immunopathogenesis of inflammatory myopathies. Ann Neurol 37 [Suppl 1]:S74\u2013S86","journal-title":"Ann Neurol"},{"key":"1027_CR7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","volume":"16","author":"K Arahata","year":"1984","unstructured":"Arahata K, Engel AG (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 16:193\u2013208","journal-title":"Ann Neurol"},{"key":"1027_CR8","first-page":"205","volume":"16","author":"S Carpenter","year":"1981","unstructured":"Carpenter S, Karpati G (1981) The major inflammatory myopathies of unknown cause. Pathol Annu 16:205\u2013237","journal-title":"Pathol Annu"},{"key":"1027_CR9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","volume":"314","author":"JT Kissel","year":"1986","unstructured":"Kissel JT, Mendell JR, Rammohan KW (1986) Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 314:329\u2013334","journal-title":"N Engl J Med"},{"key":"1027_CR10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0022-510X(89)90228-1","volume":"94","author":"M De Visser","year":"1989","unstructured":"De Visser M, Emslie-Smith AM, Engel AG (1989) Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle. J Neurol Sci 94:181\u2013192","journal-title":"J Neurol Sci"},{"key":"1027_CR11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410270402","volume":"27","author":"AM Emslie-Smith","year":"1990","unstructured":"Emslie-Smith AM, Engel AG (1990) Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 27:343\u2013356","journal-title":"Ann Neurol"},{"key":"1027_CR12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1055\/s-0038-1648506","volume":"67","author":"ZM Ruggeri","year":"1992","unstructured":"Ruggeri ZM, Ware J (1992) The structure and function of von Willebrand factor. Thromb Haemost 67:594\u2013599","journal-title":"Thromb Haemost"},{"key":"1027_CR13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1172\/JCI112560","volume":"78","author":"EJ Bowie","year":"1986","unstructured":"Bowie EJ, Solberg LA, Jr., Fass DN et al (1986) Transplantation of normal bone marrow into a pig with severe von Willebrand\u2019s disease. J Clin Invest 78:26\u201330","journal-title":"J Clin Invest"},{"key":"1027_CR14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1172\/JCI112853","volume":"79","author":"KK Hamilton","year":"1987","unstructured":"Hamilton KK, Sims PJ (1987) Changes in cytosolic Ca2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. Study of microcarrier cell monolayers using the fluorescent probe indo-1. J Clin Invest 79:600\u2013608","journal-title":"J Clin Invest"},{"key":"1027_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI112771","volume":"79","author":"JA Ribes","year":"1987","unstructured":"Ribes JA, Francis CW, Wagner DD (1987) Fibrin induces release of von Willebrand factor from endothelial cells. J Clin Invest 79:117\u2013123","journal-title":"J Clin Invest"},{"key":"1027_CR16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/ard.46.6.441","volume":"46","author":"AD Woolf","year":"1987","unstructured":"Woolf AD, Wakerley G, Wallington TB, Scott DG, Dieppe PA (1987) Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis 46:441\u2013447","journal-title":"Ann Rheum Dis"},{"key":"1027_CR17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/27.4.281","volume":"27","author":"M Greaves","year":"1988","unstructured":"Greaves M, Malia RG, Milford Ward A et al (1988) Elevated von Willebrand factor antigen in systemic sclerosis: relationship to visceral disease. Br J Rheumatol 27:281\u2013285","journal-title":"Br J Rheumatol"},{"key":"1027_CR18","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1164\/ajrccm.157.3.9705034","volume":"157","author":"S Kayal","year":"1998","unstructured":"Kayal S, Jais JP, Aguini N, Chaudiere J, Labrousse J (1998) Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 157:776\u2013784","journal-title":"Am J Respir Crit Care Med"},{"key":"1027_CR19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000046673","volume":"22","author":"SH Jacobson","year":"2002","unstructured":"Jacobson SH, Egberg N, Hylander B, Lundahl J (2002) Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Am J Nephrol 22:42\u201347","journal-title":"Am J Nephrol"},{"key":"1027_CR20","first-page":"17","volume":"30","author":"S Kida","year":"1990","unstructured":"Kida S (1990) Studies on von Willebrand factor antigen in endothelial cells and sera of patients with connective tissue diseases. Ryumachi 30:17\u201325","journal-title":"Ryumachi"},{"key":"1027_CR21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1128\/CDLI.4.5.519-521.1997","volume":"4","author":"KV Salojin","year":"1997","unstructured":"Salojin KV, Bordron A, Nassonov EL, et al (1997) Anti-endothelial cell antibody, thrombomodulin, and von Willebrand factor in idiopathic inflammatory myopathies. Clin Diagn Lab Immunol 4:519\u2013521","journal-title":"Clin Diagn Lab Immunol"},{"key":"1027_CR22","first-page":"739","volume":"21","author":"J Guzman","year":"1994","unstructured":"Guzman J, Petty RE, Malleson PN (1994) Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes. J Rheumatol 21:739\u2013743","journal-title":"J Rheumatol"},{"key":"1027_CR23","first-page":"320","volume":"22","author":"BJ Bloom","year":"1995","unstructured":"Bloom BJ, Tucker LB, Miller LC, Schaller JG (1995) von Willebrand factor in juvenile dermatomyositis. J Rheumatol 22:320\u2013325","journal-title":"J Rheumatol"},{"key":"1027_CR24","first-page":"668","volume":"22","author":"K Tanimoto","year":"1995","unstructured":"Tanimoto K, Nakano K, Kano S et al (1995) Classification criteria for polymyositis and dermatomyositis. J Rheumatol 22:668\u2013674","journal-title":"J Rheumatol"},{"key":"1027_CR25","volume-title":"Muscle testing","author":"HJ Hislop","year":"1995","unstructured":"Hislop HJ, Montgomery J (1995) Muscle testing, 6th edn. WB Saunders, Philadelphia","edition":"6"},{"key":"1027_CR26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1423-0410.1995.tb02579.x","volume":"68","author":"M Shima","year":"1995","unstructured":"Shima M, Fujimura Y, Nishiyama T et al (1995) ABO blood group genotype and plasma von Willebrand factor in normal individuals. Vox Sang 68:236\u2013240","journal-title":"Vox Sang"},{"key":"1027_CR27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2169\/internalmedicine.39.128","volume":"39","author":"K Son","year":"2000","unstructured":"Son K, Tomita Y, Shimizu T et al (2000) Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis. Intern Med 39:128\u2013135","journal-title":"Intern Med"},{"key":"1027_CR28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0038-1649589","volume":"70","author":"MG Conlan","year":"1993","unstructured":"Conlan MG, Folsom AR, Finch A et al (1993) Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 70:380\u2013385","journal-title":"Thromb Haemost"},{"key":"1027_CR29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/0046-8177(92)90400-W","volume":"23","author":"R Estruch","year":"1992","unstructured":"Estruch R, Grau JM, Fernandez-Sola J et al (1992) Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy. Hum Pathol 23:888\u2013895","journal-title":"Hum Pathol"},{"key":"1027_CR30","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1016\/S0021-9258(18)81901-9","volume":"264","author":"R Hattori","year":"1989","unstructured":"Hattori R, Hamilton KK, McEver RP, Sims PJ (1989) Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 264:9053\u20139060","journal-title":"J Biol Chem"},{"key":"1027_CR31","first-page":"1105","volume":"20","author":"R Mader","year":"1993","unstructured":"Mader R, Keystone EC (1993) Inflammatory myopathy\u2013do we have adequate measures of the treatment response? J Rheumatol 20:1105\u20131107","journal-title":"J Rheumatol"},{"key":"1027_CR32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00002281-199611000-00002","volume":"8","author":"LG Rider","year":"1996","unstructured":"Rider LG (1996) Assessment of disease activity and its sequelae in children and adults with myositis. Curr Opin Rheumatol 8:495\u2013506","journal-title":"Curr Opin Rheumatol"},{"key":"1027_CR33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/art.1780300212","volume":"30","author":"LJ Kagen","year":"1987","unstructured":"Kagen LJ, Aram S (1987) Creatine kinase activity inhibitor in sera from patients with muscle disease. Arthritis Rheum 30:213\u2013217","journal-title":"Arthritis Rheum"},{"key":"1027_CR34","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0889-857X(21)00069-7","volume":"20","author":"TJ Bohlmeyer","year":"1994","unstructured":"Bohlmeyer TJ, Wu AH, Perryman MB (1994) Evaluation of laboratory tests as a guide to diagnosis and therapy of myositis. Rheum Dis Clin North Am 20:845\u2013856","journal-title":"Rheum Dis Clin North Am"},{"key":"1027_CR35","first-page":"514","volume":"28","author":"R Frijns","year":"2001","unstructured":"Frijns R, Fijnheer R, Schiel A et al (2001) Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers. J Rheumatol 28:514\u2013519","journal-title":"J Rheumatol"},{"key":"1027_CR36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7326\/0003-4819-111-2-143","volume":"111","author":"PH Plotz","year":"1989","unstructured":"Plotz PH, Dalakas M, Leff RL et al (1989) Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 111:143\u2013157","journal-title":"Ann Intern Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-004-1027-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-004-1027-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-004-1027-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T08:54:33Z","timestamp":1624956873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-004-1027-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,23]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["1027"],"URL":"https:\/\/doi.org\/10.1007\/s10067-004-1027-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,23]]}}}